[1]Patent:US2003/92720,2003,A1
[1]Chen,Lingfeng;Chen,Hongjin;Chen,Pengqin;Zhang,Wenxin;Wu,Chao;Sun,Chuchu;Luo,Wu;Zheng,Lulu;Liu,Zhiguo;Liang,Guang[EuropeanJournalofMedicinalChemistry,2019,vol.161,p.22-38]
19735-74-1
28599-72-6
324579-90-0
28599-75-9
7496-55-1
79932-24-4
1343283-03-3 | 5,7-dimethoxyquinolin-2-amine | AA01BEJL | MFCD19678418
22531-07-3 | 3-(Propan-2-yl)-2,3-dihydro-1h-inden-1-one | AA01BEOG | MFCD16301548
1803587-59-8 | 2-(4-Ethyl-4h-1,2,4-triazol-3-yl)morpholine dihydrochloride | AA01BEYH | MFCD28118466
1247475-08-6 | 5-(chloromethyl)-3-[(3-fluorophenyl)methyl]-1,2,4-oxadiazole | AA01BF5F | MFCD14598987
1795287-42-1 | 3-(4,4-Difluorocyclohexyl)-1H-pyrazol-5-amine | AA01BFBS | MFCD24266477
1248920-92-4 | [1-(4-chlorophenyl)-2-methoxyethyl](methyl)amine | AA01BFGX | MFCD14691109
1788624-39-4 | 1-Cyclopropylpiperidine-4-carboxylic acid hydrochloride | AA01BFLM | MFCD08543838
1540203-63-1 | O-[(4-methylmorpholin-2-yl)methyl]hydroxylamine | AA01BFPR | MFCD21920874
1179086-88-4 | N-Methyl-1-(pyrazin-2-yl)piperidin-4-amine | AA01BFUT | MFCD12154980
1341372-69-7 | (3-[(3-Fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl)methanol | AA01BFYM | MFCD18878767